Covaxin effective against Delta Plus variant, says ICMR study
According to a recent research from the Indian Council of Medical Research (ICMR), covaxin is effective against the Delta Plus (AY.1) form of the SARS-CoV2 virus. The research found that Covaxin is effective against Delta, AY.1 (Delta Plus), and some other related variants. Bharat Biotech's first interim analysis result, published in March, indicated that Covaxin had an effectiveness of almost 81%. In the last analysis report of third clinical trial, the vaccine has been found with an effectiveness of almost 78.8%. Bharat Biotech, which developed Covaxin stated on August 2 that, it is effective against Delta variant.